Investment
Features
FeesSafety
Academy
More
Pluang+

Nearly $101M in Tether (USDT) moved to Bitfinex from an unknown wallet on Oct 20

Market News
20 Oct 2026
Tokenpost
View Source
Neutral
Nearly $101M in Tether (USDT) moved to Bitfinex from an unknown wallet on Oct 20

On October 20, an unknown wallet transferred 100,980,000 Tether (USDT), valued at nearly $101 million, to the Bitfinex crypto exchange via the Ethereum network. This large transfer indicates a significant movement of USDT to an exchange-linked address but does not confirm whether the tokens were sold, exchanged, or held on the platform. The identity of the wallet owner and the intent behind the transfer remain unknown, as the transaction only shows the token movement, not any subsequent trading activity. Such large transfers can signal potential market activity but require further observation to understand their impact.

The large USDT transfer to Bitfinex provides context for digital asset movements. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 21, 2026 02:31 WIB: Of 50 major cryptocurrencies priced on Pluang, 44 rose and 5 fell. Notable movers include VET at Rp126 (+4.80%), GRT at Rp448 (+4.71%), and MANA at Rp1,560 (+4.14%).

More News

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
29 minutes ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
1 hour ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
1 hour ago
CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...

Others
Neutral
1 hour ago
Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App